CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811173868
- Phone
- 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $10,270
- in 1 filing
- Open-market sales, last 90 days
- $101,136
- in 4 filings, $6K under 10b5-1 plans
Net −$90,866. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-09 | Regnante Keith Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −20,000 | 93,622 | ||
| 2023-06-08 | Regnante Keith Chief Financial Officer | Option exercise 10b5-1 | +20,000 | $16.00 | $320K | 20,000 |
| 2023-06-08 | Regnante Keith Chief Financial Officer | Sale 10b5-1 | −17,301 | $47.66 | $825K | 2,699 |
| 2023-06-08 | Regnante Keith Chief Financial Officer | Sale 10b5-1 | −2,699 | $48.65 | $131K | 0 |
| 2023-06-08 | Regnante Keith Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −20,000 | 113,622 | ||
| 2023-06-06 | GORDON CARL L Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2023-06-06 | Seth Alpna Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2023-06-06 | Kariv Tomer Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2023-06-06 | Nussbaum Ran Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2023-06-06 | Knowles Julius Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2023-06-06 | GRAY MARY ANN Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2023-06-06 | Farzan Nima Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2023-05-01 | Seth Alpna Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-04-08 | Seehra Jasbir Chief Executive Officer | Option exercise | +4,000 | $0.48 | $2K | 252,856 |
| 2023-04-08 | Seehra Jasbir Chief Executive Officer | Option exercise · Employee Stock Option (right to buy) | −4,000 | 45,087 | ||
| 2023-02-16 | Rovaldi Christopher Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-02-16 | Cooper Simon Peter Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-02-16 | Regnante Keith Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-02-16 | Seehra Jasbir Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-11-29 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Option exercise | −3,539 | $0.00 | $0 | 2,284,612 |
Page 7 of 9 · 173 trades